Tibshirani, Robert
Tibshirani, Robert
Active:
Title: New Statistical Methods for Medical Signals and Images
Time Commitments: 15%
Supporting Agency: NIH,
Name and Address of the Funding Agency’s Procuring Contracting/Grants Officer: Grace Peng, 2DEM - Two Democracy Plz, 200, 6707 Democracy Blvd Bethesda, MD 20892 Performance Period: 7/1/03 – 6/30/08
Level of Funding: $1,487,853
Brief Description of the Project’s Goals: To develop methods for analyzing microarray data and medical data that comes in the form of signals or images such as MRI and FMRI scans, and protein mass spec.
List of the Specific Aims: development of statistical methods for signals and images, and testing them on simulated and real data
Title: Flexible and Adaptive Statistical Methods
Time Commitments: 10%
Supporting Agency: NSF
Name and Address of the Funding Agency’s Procuring Contracting/Grants Officer:
Gabor J. Szekely, National Science Foundation, 4201 Wilson Boulevard, Room 1025, Arlington, VA 22230
Performance Period: 8/1/07 – 7/31/10
Level of Funding: $78,460
Brief Description of the Project’s Goals: To develop statistical methods for model selection and combination, and write a textbook on modern statistical learning methods.
List of the Specific Aims: (a) development of statistical methods for model selection and combination, (b) Completion of 2nd ed of text "Element of Statistical Learning"
Title: Proteomic Analysis of Blood Components in Autoimmune Disease
Time Commitments: 5%
Supporting Agency: NIH, NHLBI
Name and Address of the Funding Agency’s Procuring Contracting/Grants Officer:
Performance Period: 9/30/02 – 9/29/09
Level of Funding: $1,320,750
Brief Description of the Project’s Goals: The major goal of this project is to develop proteomic approaches to studying autoimmune disease. The $1,350,763 is the total direct cost for our Proteomic Center.
List of the Specific Aims: development of statistical methods for studying autoimmune disease, specifically RA.
Title: Immunological Signals and the Control of Lymphoma
Time Commitments: 2%
Supporting Agency: Leukemia and Lymphoma Society
Name and Address of the Funding Agency’s Procuring Contracting/Grants Officer:
Performance Period: 10/1/05 – 9/30/10
Level of Funding: $1,042,000
Brief Description of the Project’s Goals: Studies of cell signaling and lymphoma
List of the Specific Aims: development of statistical methods for studying for
studies of cell signaling and lymphoma
Title: Center of Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR)
Time Commitments: 0%
Supporting Agency: NIH
Name and Address of the Funding Agency’s Procuring Contracting/Grants Officer:
Piotr Grodzinski, Building 31 - Claude D Pepper Bldg, 10A52 31 Center Dr
Bethesda, MD 20892
Performance Period: 5/12/06 – 4/30/11
Level of Funding: $2,811,477
Brief Description of the Project’s Goals: Applications of nano-technology to the understanding and treatment of prostate cancer
List of the Specific Aims: develop and assess statistical methodology for nano-technology
Title: Hepatitis C: Studies of Immunity and Pathogenesis
Time Commitments: 5%
Supporting Agency: Rockefeller University
Name and Address of the Funding Agency’s Procuring Contracting/Grants Officer:
Performance Period: 7/1/05 – 6/30/10
Level of Funding: $169,892
Brief Description of the Project’s Goals: Assisting in microarray analysis
List of the Specific Aims: Consult with investigators on issues in microarray analysis
Title: Expression Profiling for Improved Risk Stratification in Normal Karyotype
Time Commitments: 5%
Supporting Agency: Leukemia and Lymphoma Society
Name and Address of the Funding Agency’s Procuring Contracting/Grants Officer:
Performance Period: 10/1/05 – 9/30/08
Level of Funding: $200,000
Brief Description of the Project’s Goals: Gene expression methodology for risk stratification in adult leukemia
List of the Specific Aims: Model expression signatures and correlate the signatures with
risk groups
Title: Clinical and Laboratory Studies of Malignant Lymphomas
Time Commitments: 20%
Supporting Agency: NIH
Name and Address of the Funding Agency’s Procuring Contracting/Grants Officer:
William Merritt, EPN - Exec Plz North, 7014 6130 Executive Blvd
Rockville, MD 20852
Performance Period: 7/17/06 – 3/31/11
Level of Funding: $1,086,564
Brief Description of the Project’s Goals: Studies of cell signaling and lymphoma
List of the Specific Aims:
Title: Tumor Hypoxia: Molecular Studies and Clinical Exploitation
Time Commitments: 0%
Supporting Agency: NIH
Name and Address of the Funding Agency’s Procuring Contracting/Grants Officer:
Helen Stone, EPN - Exec Plz North, 6008, 6130 Executive Blvd Rockville, MD 20852
Performance Period: 2/9/07 – 1/31/12
Level of Funding: $1,005,391
Brief Description of the Project’s Goals: Studying the role of tumor hypoxia for treatment of head and neck cancer
List of the Specific Aims: Consult with investigators on issues in microarray analysis
Title: Massachusetts General Hospital Study
Time Commitments: 5%
Supporting Agency: Massachusetts General Hospital
Name and Address of the Funding Agency’s Procuring Contracting/Grants Officer:
Performance Period: 9/31/01 – 8/31/08
Level of Funding: $636,818
Brief Description of the Project’s Goals: Genomic and proteomic studies of burns and trauma
List of the Specific Aims: develop and test gene expression and protein-based predictor
of recovery in burn and trauma patients
Title: Prognostic Models in Diffuse Large B-Cell Lymphoma
Time Commitments: 5%
Supporting Agency: NIH
Name and Address of the Funding Agency’s Procuring Contracting/Grants Officer:
Performance Period: 9/24/07 – 7/31/11
Level of Funding: $68,792
Brief Description of the Project’s Goals:
List of the Specific Aims: Develop and test pognostic Models in Diffuse Large B-Cell Lymphoma
Pending:
Title: Genome-wide Association in Early-onset Breast Cancer
Time Commitments: 10%
Supporting Agency: Columbia University
Name and Address of the Funding Agency’s Procuring Contracting/Grants Officer:
Performance Period: 7/1/06 – 6/30/11
Level of Funding: $1,009,615
Brief Description of the Project’s Goals: Assist identification of SNP’s that relate to breast cancer
List of the Specific Aims: Model and assess the correlation between SNPs and phenotypes in Early-onset Breast Cancer.
Title: Discovery of Gene Expression Signatures in Cancer Stroma
Time Commitments: 7%
Supporting Agency: Palo Alto Institute for Research Education
Name and Address of the Funding Agency’s Procuring Contracting/Grants Officer:
Performance Period: 7/1/07 – 6/30/12
Level of Funding: $396,916
Brief Description of the Project’s Goals: Statistical analysis of gene expression data in Stroma
List of the Specific Aims: Estimate of gene expression stroma signatures and assess their
prognostic power in breast cancer and other cancer datasets
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- robert my 600 pound life
- robert stephens convention center rosemont il
- robert marzano 9 instructional strategies
- robert kiyosaki
- robert kiyosaki books
- robert half finance accounting
- robert palmer mortgage complaints
- robert half accounting jobs
- robert half part time jobs
- robert allen marriott
- robert glover books
- robert g anderson md